These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 1979339)

  • 1. Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.
    Cefai D; Debre P; Kaczorek M; Idziorek T; Autran B; Bismuth G
    J Clin Invest; 1990 Dec; 86(6):2117-24. PubMed ID: 1979339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CD4+ T cell activation and adhesion by peptides derived from the gp160.
    Corado J; Mazerolles F; Le Deist F; Barbat C; Kaczorek M; Fischer A
    J Immunol; 1991 Jul; 147(2):475-82. PubMed ID: 1677023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71).
    Chirmule N; McCloskey TW; Hu R; Kalyanaraman VS; Pahwa S
    J Immunol; 1995 Jul; 155(2):917-24. PubMed ID: 7541827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation.
    Cefai D; Ferrer M; Serpente N; Idziorek T; Dautry-Varsat A; Debre P; Bismuth G
    J Immunol; 1992 Jul; 149(1):285-94. PubMed ID: 1535086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD45 modulates T cell receptor/CD3-induced activation of human thymocytes via regulation of tyrosine phosphorylation.
    Turka LA; Kanner SB; Schieven GL; Thompson CB; Ledbetter JA
    Eur J Immunol; 1992 Feb; 22(2):551-7. PubMed ID: 1371471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
    Hubert P; Bismuth G; Körner M; Debré P
    Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD2/LFA-3 ligation induces phospholipase-C gamma 1 tyrosine phosphorylation and regulates CD3 signaling.
    Kanner SB; Damle NK; Blake J; Aruffo A; Ledbetter JA
    J Immunol; 1992 Apr; 148(7):2023-9. PubMed ID: 1372020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ca2+ influx in human T lymphocytes is induced independently of inositol phosphate production by mobilization of intracellular Ca2+ stores. A study with the Ca2+ endoplasmic reticulum-ATPase inhibitor thapsigargin.
    Gouy H; Cefai D; Christensen SB; Debré P; Bismuth G
    Eur J Immunol; 1990 Oct; 20(10):2269-75. PubMed ID: 1700752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does co-aggregation of the CD45 and CD3 antigens inhibit T cell antigen receptor complex-mediated activation of phospholipase C and protein kinase C?
    Shivnan E; Biffen M; Shiroo M; Pratt E; Glennie M; Alexander D
    Eur J Immunol; 1992 Apr; 22(4):1055-62. PubMed ID: 1532359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochalasins enhance the proliferation of CD4 cells through the CD3-Ti antigen receptor complex or the CD2 molecule through an effect on early events of activation.
    Matsuyama T; Yamada A; Deusch K; Sleasman J; Daley JF; Torimoto Y; Abe T
    J Immunol; 1991 Jun; 146(11):3736-41. PubMed ID: 1709660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV inhibits the early steps of lymphocyte activation, including initiation of inositol phospholipid metabolism.
    Hofmann B; Nishanian P; Baldwin RL; Insixiengmay P; Nel A; Fahey JL
    J Immunol; 1990 Dec; 145(11):3699-705. PubMed ID: 1978848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD2 can mediate TCR/CD3-independent T cell activation.
    Ohno H; Ushiyama C; Taniguchi M; Germain RN; Saito T
    J Immunol; 1991 Jun; 146(11):3742-6. PubMed ID: 1674520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling requirements for the expression of the transactivating factor NF-AT in human T lymphocytes.
    Hivroz-Burgaud C; Clipstone NA; Cantrell DA
    Eur J Immunol; 1991 Nov; 21(11):2811-9. PubMed ID: 1682154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficiency virus transcription.
    Gruters RA; Otto SA; Al BJ; Verhoeven AJ; Verweij CL; Van Lier RA; Miedema F
    Eur J Immunol; 1991 Jan; 21(1):167-72. PubMed ID: 1846814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sgp-60, a signal-transducing glycoprotein concerned with T cell activation through the T cell receptor/CD3 complex.
    Reiser H
    J Immunol; 1990 Oct; 145(7):2077-86. PubMed ID: 1975823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodeficiency with low expression of the T cell receptor/CD3 complex. Effect on T lymphocyte activation.
    Le Deist F; Thoenes G; Corado J; Lisowska-Grospierre B; Fischer A
    Eur J Immunol; 1991 Jul; 21(7):1641-7. PubMed ID: 1676369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of negative signal through CD2 during antigen-specific T cell activation.
    Ohno H; Nakamura T; Yagita H; Okumura K; Taniguchi M; Saito T
    J Immunol; 1991 Oct; 147(7):2100-6. PubMed ID: 1680913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking of VLA/CD29 molecule has a co-mitogenic effect with anti-CD3 on CD4 cell activation in serum-free culture system.
    Yamada A; Nojima Y; Sugita K; Dang NH; Schlossman SF; Morimoto C
    Eur J Immunol; 1991 Feb; 21(2):319-25. PubMed ID: 1705510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.